Alafair Biosciences Awarded Synthetic Implantable Products Agreement With Premier, Inc. for VersaWrap Hydrogel Sheet
Alafair Biosciences Awarded Synthetic Implantable Products Agreement With Premier, Inc. for VersaWrap Hydrogel Sheet
AUSTIN, Texas, July 2, 2024 /PRNewswire/ -- Alafair Biosciences, Inc., is revolutionizing soft tissue protection with innovative hydrogel medical devices, today announced that its flagship product, VersaWrap Hydrogel Sheet (VersaWrap), has been awarded a national group purchasing agreement with Premier, Inc. Effective July 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for VersaWrap. VersaWrap is a class II medical device that allows tissues to glide and to remain untethered, thereby reducing reoperations and improving patient outcomes.
得克薩斯州奧斯汀，2024年7月2日 /PRNewswire/ — Alafair Biosciences, Inc. 正在通過創新的水凝膠醫療器械徹底改變軟組織保護。該公司今天宣佈，其旗艦產品VersaWrap Hydrogel Sheet（VersaWrap）已與Premier, Inc.簽訂了全國團體採購協議。自2024年7月1日起，新協議允許Premier會員自行決定使用特價和預條款由總理爲 VersaWrap 進行談判。VersaWrap 是一種 II 類醫療設備，它允許組織滑行並保持不受束縛，從而減少再手術並改善患者預後。
"We are honored that Premier and its members reviewed our technology and awarded Alafair an agreement," stated John Joyoprayitno, President & CEO of Alafair Biosciences. "This agreement provides a meaningful opportunity for Alafair to broaden VersaWrap's reach to Premier members, clinicians, and, most importantly, patients nationwide. We anticipate this agreement to further fuel our momentum and enable us to continue delivering over 100% year-over-year growth."
Alafair Biosciences總裁兼首席執行官約翰·喬約普拉伊特諾表示：“我們很榮幸Premier及其成員審查了我們的技術並與Alafair簽訂了協議。”“該協議爲Alafair提供了一個有意義的機會，可以將VersaWrap的影響範圍擴大到Premier會員、臨床醫生，最重要的是全國患者。我們預計，該協議將進一步推動我們的勢頭，使我們能夠繼續實現超過100％的同比增長。”
Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,350 U.S. hospitals and 300,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, consulting, and other services, Premier enables better care and outcomes at a lower cost.
Premier 是一家領先的醫療保健改善公司，它聯合了一個由大約 4,350 家美國醫院和 300,000 家其他提供商組成的聯盟，以實現醫療保健的轉型。憑藉集成的數據和分析、協作、供應鏈解決方案、諮詢和其他服務，Premier 能夠以更低的成本提供更好的護理和結果。
About Alafair Biosciences, Inc.
關於 Alafair Biosciences, Inc.
Alafair is a privately held medical device company developing and marketing an innovative product portfolio based on its proprietary hydrogel technology. The mission of Alafair is to revolutionize surgical care with our versatile hydrogel technology, delivering unparalleled value to patients, surgeons, and healthcare facilities by enhancing soft tissue protection and by elevating patient outcomes. Alafair products are distributed through a dispersed network of independent distributors across the United States.
Alafair是一傢俬營醫療器械公司，基於其專有水凝膠技術開發和銷售創新產品組合。Alafair 的使命是利用我們的多功能水凝膠技術徹底改變外科護理，通過增強軟組織保護和提升患者預後，爲患者、外科醫生和醫療機構提供無與倫比的價值。Alafair 產品通過分散在美國的獨立分銷商網絡進行分銷。
About VersaWrap Hydrogel Sheet
關於 VersaWrap 水凝膠片
VersaWrap is an FDA-cleared medical device implant (not tissue) comprising hyaluronic acid (HA) and alginate that provides a gelatinous encasement for peripheral nerves, tendons, and surrounding tissues such as ligaments and skeletal muscles. Our innovative technology allows tissues to glide and to remain untethered, thereby reducing reoperations and improving patient outcomes. VersaWrap offers unique surgical flexibility as the only tendon and nerve protector that can be delivered either as a sheet or as a flowable gel.
VersaWrap 是美國食品藥品管理局批准的醫療器械植入物（非組織），含有透明質酸（HA）和海藻酸鹽，可爲周圍神經、肌腱和周圍組織（如韌帶和骨骼肌）提供凝膠狀包裹。我們的創新技術使組織能夠滑動並保持不受束縛，從而減少再手術並改善患者預後。VersaWrap 具有獨特的手術靈活性，是唯一可以以片狀或可流動凝膠形式輸送的肌腱和神經保護劑。
SOURCE Alafair Biosciences, Inc.
來源 Alafair Biosciences, Inc.
譯文內容由第三人軟體翻譯。